Biologics in a Box: Fewer Handoffs. Faster CGT Treatment.
Biologics in a Box is designed to streamline cell and gene therapy delivery, giving treatment centers more ordering flexibility while reducing complexity and risk for manufacturers.
Created for the Realities of CGT Delivery
Built for Advanced Therapies
Purpose-built infrastructure and CGT expertise support the unique handling, storage and delivery requirements of complex therapies.
Faster Time to Treatment
By reducing handoffs and simplifying coordination, Biologics in a Box helps therapies reach treatment centers efficiently, without limiting ordering pathways.
End-to-End Control
Distribution, logistics, pharmacy and patient services work together in one model, reducing fragmentation and administrative burden.
Delivery Without Disruptions
Biologics in a Box redefines CGT delivery by co-locating critical functions that are traditionally fragmented across multiple partners. By integrating cold chain storage and specialty pharmacy services in one environment, it reduces operational complexity and expands channel optionality for sites of care, while minimizing risk, delays, and variability across the treatment journey.
Frequently Asked Questions About Biologics in a Box
What is the Biologics in a Box solution?
Biologics in a Box is a proprietary model developed by InspiroGene™ by McKesson that reimagines how CGTs move from storage to administration. The model co-locates our state-of-the-art cold chain storage with CGT-dedicated specialty pharmacy services, reducing unnecessary handoffs and simplifying a fragmented supply chain.
What problem is Biologics in a Box designed to solve?
CGTs are high-value, time-sensitive and temperature-specific, making every step in the supply chain critical. Traditional multi-step distribution models introduce added complexity, delays and risk through multiple handoffs across facilities, couriers and logistics partners, all of which can directly impact when patients receive treatment.
How does the traditional CGT supply chain model introduce risk?
In many traditional models, therapies move from a cold chain storage facility to a separate specialty pharmacy before reaching the treatment center. Each handoff adds transit time, distance and administrative complexity, increasing the likelihood of delays, temperature deviations and other disruptions.
How does Biologics in a Box reduce time to treatment?
By eliminating an extra step in the supply chain, the Biologics in a Box model shortens the treatment journey and reduces risk. With fewer transitions and tighter coordination, therapies can move more efficiently toward treatment centers.
Which services are integrated in Biologics in a Box?
Biologics in a Box brings together distribution, logistics, specialty pharmacy and patient support services under one coordinated model. This integration improves coordination across the therapy journey while reducing fragmentation and operational burden for biopharma teams and CGT sites of care.
Who is Biologics in a Box built for?
Biologics in a Box is designed for CGT manufacturers who need precise, low-risk coordination and delivery of their therapies from storage to administration, and those that want to provide their treatment centers with added flexibility in how therapies are ordered.
What role does the specialty pharmacy channel play in this model?
The specialty pharmacy channel can play a key role in helping treatment centers manage the operational and administrative demands of CGT delivery. As part of Biologics in a Box, specialty pharmacy services can help reduce complexity and minimize risk for treatment centers expanding their CGT programs.